Related Experiment Video

Updated: Sep 25, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.7K

Willingness to receive COVID-19 vaccination in people living with HIV/AIDS from Latin America

Yeimer Ortiz-Martínez1,2, Miguel Ángel López-López3, Carlos E Ruiz-González1

  • 1Department of Internal Medicine, 469618Universidad Industrial de Santander, Bucaramanga, Colombia.

International Journal of STD & AIDS
|April 29, 2022
PubMed

Insights

Most people living with HIV/AIDS (PLWHA) are willing to receive COVID-19 vaccines, citing protection and reduced transmission. Prioritizing PLWHA in vaccination plans is supported, with strategies needed to address hesitancy.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Limited understanding of HIV's impact on COVID-19 severity and SARS-CoV-2 susceptibility.
  • Gaps exist in data on COVID-19 vaccination willingness among people living with HIV/AIDS (PLWHA), especially in developing nations.
  • Need for evidence to inform prioritization of PLWHA in global vaccination strategies.

Purpose of the Study:

  • To assess COVID-19 vaccination willingness among PLWHA.
  • To identify reasons for vaccination willingness and hesitancy in this population.
  • To inform public health strategies for vaccine rollout.

Main Methods:

  • Cross-sectional, descriptive-analytical study design.
  • Online electronic surveys distributed via Twitter to PLWHA in February 2021.
  • Data collected from HIV activist social media accounts.

Main Results:

  • High willingness (87.1%) to receive COVID-19 vaccines among PLWHA.
  • Key motivators: belief in vaccine efficacy for prevention and reduced transmission, occupational risk, and fear of severe COVID-19 outcomes.
  • Low rates of vaccine hesitancy (10.6%) and unwillingness (2.2%).

Conclusions:

  • Findings support prioritizing PLWHA in vaccination programs, particularly in developing countries.
  • Development of targeted strategies is crucial to address vaccine hesitancy and refusal in at-risk populations.
  • Public health initiatives should consider the specific needs and concerns of PLWHA regarding COVID-19 vaccination.
Abstract

Keywords:
Coronavirus disease 2019coronavirus disease 2019 vaccinepeople Living with human immunodeficiency virus/AIDSvaccine hesitancyvaccine unwillingnessvaccine willingness

More Related Videos

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

15.7K
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.8K

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
433
Vaccinations01:51

Vaccinations

Overview
45.4K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.2K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
340
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
531